Argos in The News
Argos Therapeutics Licenses Arcelis(R) Technology Platform to Lummy HK for Development of Personalized Immunotherapies to Treat Cancer in China
Argos Therapeutics to Present at the 14th Annual Needham Healthcare Conference
NIH Funds Study of Fully Personalized Immunotherapy AGS-004 Combined With a Latency Reversing Therapy for the Treatment of HIV
> More News & Events Here.